Difficulty: Medium
Average Score: 85%
Practice
For limiting cerebral edema due to brain tumor, the preferred corticosteroids are betamethasone/dexamethasone because
Correct answer
A
Rationale
In the treatment of cerebral edema due to brain tumors, the preferred corticosteroids are betamethasone/dexamethasone because they do not cause Na+ and water retention (Option A). This is crucial in managing cerebral edema as excess sodium and water retention can exacerbate brain swelling and increase intracranial pressure, leading to further complications.
Option B is incorrect because the potency of corticosteroids is not the primary concern when selecting a corticosteroid for managing cerebral edema. The key consideration is the side effect profile and the specific mechanism of action related to reducing edema.
Option C is incorrect because both betamethasone and dexamethasone can be administered intravenously, so this does not differentiate between the two corticosteroids in terms of their preference for managing cerebral edema.
Option D is incorrect because corticosteroids like betamethasone and dexamethasone are not used to directly inhibit brain tumors. Their primary role in this context is to reduce inflammation and edema surrounding the tumor to alleviate symptoms and improve the patient's quality of life.
In an educational context, understanding the rationale behind selecting specific medications for the treatment of cerebral edema is essential for healthcare professionals involved in the care of patients with brain tumors. Knowing the differences between corticosteroids in terms of their side effect profiles and mechanisms of action can help clinicians make informed decisions to provide optimal care for their patients.
Option B is incorrect because the potency of corticosteroids is not the primary concern when selecting a corticosteroid for managing cerebral edema. The key consideration is the side effect profile and the specific mechanism of action related to reducing edema.
Option C is incorrect because both betamethasone and dexamethasone can be administered intravenously, so this does not differentiate between the two corticosteroids in terms of their preference for managing cerebral edema.
Option D is incorrect because corticosteroids like betamethasone and dexamethasone are not used to directly inhibit brain tumors. Their primary role in this context is to reduce inflammation and edema surrounding the tumor to alleviate symptoms and improve the patient's quality of life.
In an educational context, understanding the rationale behind selecting specific medications for the treatment of cerebral edema is essential for healthcare professionals involved in the care of patients with brain tumors. Knowing the differences between corticosteroids in terms of their side effect profiles and mechanisms of action can help clinicians make informed decisions to provide optimal care for their patients.